Artiva Biotherapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Artiva Biotherapeutics Inc had 20.95M in cash and cash equivalents.

Artiva Biotherapeutics Inc reported 20.97M in total liabilities as of the latest reported quarter, including 13.09M in current liabilities and 7.88M in non-current liabilities.

As of the latest reported quarter, Artiva Biotherapeutics Inc's total assets were 130.94M, consisting of 112.67M in current assets and 18.27M in non-current assets.

Artiva Biotherapeutics Inc reported 109.97M in total shareholders' equity as of the latest reported quarter.